Decision Making SIG

Members can access private content by clicking here.

The Quantitative Decision-making Special Interest Group (QDM SIG) was formed in October 2017. It is a group of statisticians from industry and academia, with experience and interests in statistical methods for quantitative decision-making in drug development. The objectives of the SIG are:
To share (anonymized) case studies of how quantitative decision-making methods have been used within pharmaceutical companies, for decisions at the trial level, at the development level and at the portfolio level
To perform literature reviews, discuss and make recommendations on existing methodologies in terms of approach and interpretation
To develop new methodologies or practices where needed
To promote the role of the statistician in supporting decision-making in pharmaceutical companies and/or other stakeholders 
To propose trainings, public meetings or publications to share methods and experience

For further information, or to join the QDM SIG, please contact the co-chairs:
Pierre Colin (Sanofi)
Gaelle Saint-Hilary (Politecnico di Torino)

To access the Decision Making In Drug Development event presentations and posters please click here